CJC-1295 without DAC is a synthetic analog of growth hormone-releasing hormone (GHRH) designed to stimulate the natural release of growth hormone (GH) from the pituitary gland. Unlike the DAC version, it does not contain the Drug Affinity Complex (DAC), resulting in a significantly shorter half-life and more rapid clearance.
Research suggests CJC-1295 without DAC may:
Increase pulsatile growth hormone release
Elevate insulin-like growth factor-1 (IGF-1) levels
Support protein synthesis and tissue repair
Influence metabolism, recovery, and body composition
Due to its shorter duration of action, CJC-1295 without DAC is often studied in combination with growth hormone secretagogues such as Ipamorelin to potentially enhance GH signaling through complementary pathways.
CJC-1295 without DAC is intended for research and laboratory use only.

